Prophylactic antibiotics after endoscopic sinus surgery for chronic rhinosinusitis: a randomized, double-blind, placebo-controlled noninferiority clinical trial.
Ashton E LehmannAaishah R RaquibShan H SiddiqiJosh MeierMarlene L DurandStacey T GrayEric H HolbrookPublished in: International forum of allergy & rhinology (2020)
Although statistically underpowered, the results suggest placebo was noninferior to prophylactic antibiotics after ESS for CRS regarding postoperative sinonasal-specific QOL. There were no significant differences in postoperative endoscopic scores or rates of infection, but the rate of diarrhea was significantly higher in the antibiotic group. These findings add to the growing evidence that routine use of prophylactic postoperative antibiotics does not improve outcomes post-ESS and significantly increases the rate of diarrhea.
Keyphrases
- double blind
- placebo controlled
- clinical trial
- chronic rhinosinusitis
- patients undergoing
- phase iii
- phase ii
- ultrasound guided
- study protocol
- randomized controlled trial
- clostridium difficile
- phase ii study
- acute coronary syndrome
- type diabetes
- weight loss
- clinical practice
- adipose tissue
- skeletal muscle
- insulin resistance
- glycemic control
- coronary artery disease
- atrial fibrillation